However, the conclusions of this work are limited due to the need to analyze a larger number of tissue samples from ovarian cancer patients and to study the association between PHF20L1 expression and the response to treatment, which could provide additional information about the role of the protein in tumor progression. This evidence concerns the gene PHF20L1 and neoplasm.